Divi's Laboratories or Sun Pharmaceutical — which is the better buy?

The honest answer comes from running the same workflow on both: quality score, valuation ceiling versus today's price, and which thesis breaks worry you more. The snapshot table below gives the current dated state of each.

How are DIVISLAB.NS and SUNPHARMA.NS different?

Divi's Laboratories trades on India (Pharma); Sun Pharmaceutical trades on India (Pharma). Market, currency, liquidity, and disclosure regimes differ — the workflow stays identical, so the comparison is fair.

Comparison · Updated 2026-08-29

Divi's Laboratories vs Sun Pharmaceutical

Which is stronger right now? The dated snapshot below answers it with quality, valuation ceiling, risk, and timing — side by side, then the full decision brief.

By the Balance Labs Research Desk · Reviewed by the editorial review board · 2026-08-29

Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.

Key facts — quick answer

DIVISLAB.NS = Divi's Laboratories (India) · SUNPHARMA.NS = Sun Pharmaceutical (India).
Snapshot 2026-08-29: DIVISLAB.NS ₹9,121 · signal LONG · ret +25.3% ‖ SUNPHARMA.NS ₹1,913 · signal LONG · ret +8.4%.
The one with the wider gap between price and its valuation ceiling — at equal quality — usually wins the slot.

Snapshot comparison (2026-08-29)

	DIVISLAB.NS	SUNPHARMA.NS
Company	Divi's Laboratories	Sun Pharmaceutical
Market	🇮🇳 India	🇮🇳 India
Sector	Pharma	Pharma
Price	₹9,121	₹1,913
Signal	LONG · +40.9%	LONG · +16.0%
Total return	+25.3%	+8.4%

Decide it with the calculator

Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.

See the full decision brief

DIVISLAB.NS decision brief SUNPHARMA.NS decision brief

Deeper comparison — Divi's Laboratories (DIVISLAB.NS) vs Sun Pharmaceutical (SUNPHARMA.NS)

Beyond the snapshot above, the real comparison comes from running the same workflow on both companies: score quality, set the valuation ceiling, and write the break conditions for each. The framework stays identical; only the data changes.

Dimension	DIVISLAB.NS	SUNPHARMA.NS
Market	🇮🇳 India	🇮🇳 India
Sector	Pharma	Pharma
STM signal	LONG	LONG
uPnL	+40.9%	+16.0%
Total return	+25.3%	+8.4%

Use this table as a starting point, not an answer. The decision comes from running the full workflow on both companies — DIVISLAB.NS brief · SUNPHARMA.NS brief — and comparing the outputs side by side.

★

Get more Balance Labs in your Google results

Add balancelabs.app as a Preferred Source on Google.

Cite this page

Balance Labs Research Desk. "Divi's Laboratories vs Sun Pharmaceutical" https://balancelabs.app/stocks/compare/divislab.ns-vs-sunpharma.ns. Data snapshot: 2026-08-29. CC BY 4.0 with attribution.

ASK STOCK CHAT

Ask anything about DIVISLAB.NS

Same AI engine as this decision brief — grounded in live tool reports.

Should I buy DIVISLAB.NS at these levels?What would break the DIVISLAB.NS thesis?DIVISLAB.NS vs SUNPHARMA.NS — which has more room?

30 free credits monthly · no card required · research support, not advice

← All guides · Home · Data snapshot 2026-08-29 · Not investment advice.